Inicio › Cáncer (todos los tipos) › Indiana › Indianapolis
Ensayos clínicos de Cáncer (todos los tipos) en Indianapolis, IN
24 estudios para Cáncer (todos los tipos) buscan participantes en centros de Indianapolis y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Daily Hand-Held Vibration Therapy
Reclutando
- Indiana University Melvin & Bren Simon Cancer Center, Indianapolis
- IU Health Joe & Shelly Schwarz Cancer Center, Indianapolis
- Indiana University Health West, Avon · A 13 mi de distancia
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
ReclutandoEstudio observacional
- Indiana University, Indianapolis
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
ReclutandoFase 3
- Franciscan Health Oncology and Hematology Specialists, Indianapolis
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
ReclutandoFase 3
- Franciscan St. Francis Health /ID# 279788, Indianapolis
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ReclutandoFase 2
- Community Health Network (The University of Texas MD Anderson Cancer Center), Indianapolis
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- Community Health Network, Indianapolis
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
ReclutandoFase 2/3
- IN Univ Simon Cancer Center, Indianapolis
- Franciscan Health Indianapolis, Indianapolis
Collection of Tissue Samples for Cancer Research
ReclutandoEstudio observacional
- Indiana University - Purdue, Indianapolis
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
- Community Cancer Center North, Indianapolis
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
ReclutandoFase 2
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Project: Every Child for Younger Patients With Cancer
ReclutandoEstudio observacional
- Riley Hospital for Children, Indianapolis
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Abatacept in Immune Checkpoint Inhibitor Myocarditis
ReclutandoFase 3
- Franciscan Health, Indianapolis
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
ReclutandoFase 3
- Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
- y 1 más
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
ReclutandoFase 1
- Franciscan St. Francis Health /ID# 280928, Indianapolis
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
ReclutandoFase 2
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
ReclutandoSe aceptan voluntarios sanos
- Indiana University School of Medicine, Indianapolis
Childhood Cancer Survivor Study
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Indiana University/Riley Hospital for Children, Indianapolis
Galleri® in the Medicare Population.
ReclutandoSe aceptan voluntarios sanos
- Community Health Network East, Indianapolis
- Community Health Network South, Indianapolis
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
Reclutando
- University Hospital Clinical Research Center, Indianapolis
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Reclutando
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
GEMINI-NSCLC: NSCLC Biomarker Study
ReclutandoEstudio observacional
- Community Health Network, Indianapolis
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- IU Simon Comprehensive Cancer Center, Indianapolis
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
ReclutandoFase 1/2
- Community Health Network, Inc., Indianapolis
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Reclutando
- Indiana University - Melvin and Bren Simon Cancer Center, Indianapolis
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Franciscan Health Indianapolis, Indianapolis
Más información sobre Cáncer (todos los tipos) en MedlinePlus
Ensayos de Cáncer (todos los tipos) en otras ciudades
- Houston, TX121 estudios
- New York City, NY109 estudios
- Boston, MA85 estudios
- Los Angeles, CA74 estudios
- Nashville, TN65 estudios
- Philadelphia, PA59 estudios
- Washington, DC58 estudios
- Durham, NC58 estudios
- Chicago, IL51 estudios
- Atlanta, GA49 estudios
- Seattle, WA49 estudios
- Arlington, VA48 estudios
Otros estudios en Indianapolis
- Cáncer de pulmón de células no pequeñas32 estudios
- Fallo cardíaco23 estudios
- Obesidad20 estudios
- Cáncer de seno20 estudios
- Cáncer metastásico19 estudios
- Cáncer del colon y del recto18 estudios
- Cáncer de ovario17 estudios
- Enfermedad cardiovascular17 estudios
- Cáncer de pulmón16 estudios
- Diabetes tipo 114 estudios
- Cáncer de endometrio14 estudios
- Enfermedad de Alzheimer14 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.